Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
PERI
CELL BIOTECH
★★★
Cell Biotech Q1 2026: Sales Up, OP +134%, Potential for Dividend and Buyback
05/15/2026, 01:56 PM
EXCH
CELL BIOTECH
★★★★
Preliminary Q1 2026 Results: Operating Profit Surges 134%, Net Income Up 158.6%
05/08/2026, 03:31 PM